Epinephrine
NDC Package 71872-7103-1

11-digit billing NDC: 71872710301

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Epinephrine is injection, USP auto-injector is indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which includes bees, wasps, hornets, yellow jackets and fire ants), and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media), and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.Epinephrine injection, USP auto-injector is intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions.Anaphylactic reactions may occur within minutes after exposure and consist of flushing, apprehension, syncope, tachycardia, thready or unobtainable pulse associated with a fall in blood pressure, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, wheezing, dyspnea due to laryngeal spasm, pruritus, rashes, urticaria, or angioedema.Epinephrine injection, USP auto-injector is intended for immediate administration as emergency supportive therapy only and is not a replacement or substitute for immediate medical care. Marketed by Medical Purchasing Solutions, Llc, this product is identified by NDC 71872-7103 and is authorized under FDA application NDA020800.

Identification & Billing

NDC Package Code
71872-7103-1
Package Description
1 CASE in 1 BAG / 1 SYRINGE, GLASS in 1 CASE / .3 mL in 1 SYRINGE, GLASS
Product Code
11-Digit Billing Format
71872710301
RxNorm Crosswalk
  • RxCUI: 1870230 - EPINEPHrine (generic for Adrenaclick) 0.3 MG in 0.3 ML Auto-Injector
  • RxCUI: 1870230 - NDA020800 0.3 ML epinephrine 1 MG/ML Auto-Injector
  • RxCUI: 1870230 - epinephrine (generic for Adrenaclick) 0.3 MG per 0.3 ML Auto-Injector

Clinical Specifications

Proprietary Name
Epinephrine
Dosage Form
-
Usage Information
Epinephrine injection, USP auto-injector is indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which includes bees, wasps, hornets, yellow jackets and fire ants), and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media), and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.Epinephrine injection, USP auto-injector is intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions.Anaphylactic reactions may occur within minutes after exposure and consist of flushing, apprehension, syncope, tachycardia, thready or unobtainable pulse associated with a fall in blood pressure, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, wheezing, dyspnea due to laryngeal spasm, pruritus, rashes, urticaria, or angioedema.Epinephrine injection, USP auto-injector is intended for immediate administration as emergency supportive therapy only and is not a replacement or substitute for immediate medical care.

Regulatory & Marketing

Labeler Name
Medical Purchasing Solutions, Llc
FDA Application #
NDA020800
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
04-01-2010
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71872-7103-1 identifies a specific commercial package of 1 case in 1 bag / 1 syringe, glass in 1 case / .3 ml in 1 syringe, glass of Epinephrine, labeled by Medical Purchasing Solutions, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Medical Purchasing Solutions, Llc on April 01, 2010. The current certification is valid through December 31, 2022.

How is this Medical Purchasing Solutions, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71872710301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
71872-7103-1
11-Digit CMS (5-4-2)
71872-7103-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.